Peel Hunt restated their buy rating on shares of Halma (LON:HLMA – Free Report) in a research report sent to investors on Thursday, Marketbeat.com reports. Peel Hunt currently has a GBX 3,750 target price on the stock.
A number of other equities analysts also recently issued reports on the company. The Goldman Sachs Group began coverage on Halma in a research report on Thursday, August 7th. They set a “buy” rating and a GBX 3,740 price target on the stock. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Halma from GBX 3,290 to GBX 3,690 and gave the company a “hold” rating in a report on Friday, October 3rd. Shore Capital reaffirmed a “hold” rating on shares of Halma in a research report on Friday, September 26th. Finally, Berenberg Bank increased their target price on shares of Halma from GBX 3,250 to GBX 3,750 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 3,455.
Get Our Latest Analysis on Halma
Halma Trading Down 2.2%
Insider Buying and Selling
In other Halma news, insider Jennifer Ward sold 15,000 shares of the firm’s stock in a transaction on Thursday, September 25th. The stock was sold at an average price of GBX 3,381, for a total value of £507,150. Company insiders own 0.81% of the company’s stock.
Halma Company Profile
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad markets it operates in:
– Safety – Protecting people’s safety and the environment as populations grow, and enhancing worker safety.
– Environment – Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.
– Health – Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.
Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific.
Featured Articles
- Five stocks we like better than Halma
- Stock Market Sectors: What Are They and How Many Are There?
- MP Materials Stock Soared After Earnings—Here’s the Real Reason
- Investing In Preferred Stock vs. Common Stock
- Why Palantir Slide May Be a Setup for a Long-Term Opportunity
- Quiet Period Expirations Explained
- Attention Income Investors: This REIT Is on Sale
Receive News & Ratings for Halma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halma and related companies with MarketBeat.com's FREE daily email newsletter.
